AMEI's Current Trends in Diagnosis & Treatment

Register      Login

VOLUME 5 , ISSUE 1 ( January-June, 2021 ) > List of Articles

REVIEW ARTICLE

Management of Rheumatoid Arthritis in Pregnancy: A Review Article

Rajdeep Singh, Parminder Singh, Sita Sharma

Keywords : Chronic inflammatory disease, Pregnancy outcomes, Rheumatoid arthritis

Citation Information : Singh R, Singh P, Sharma S. Management of Rheumatoid Arthritis in Pregnancy: A Review Article. Curr Trends Diagn Treat 2021; 5 (1):36-41.

DOI: 10.5005/jp-journals-10055-0121

License: CC BY-NC 4.0

Published Online: 00-06-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory condition, usually affecting females three times more than the males. The peak age of onset is in the childbearing age-group i.e., 19–44 years. Females with RA face difficulties at the time of conception, during pregnancy, and in the lactation period. Certain drugs used for the management of RA have deleterious effects on pregnancy outcomes. Thus, it is increasingly becoming a topic of concern as well as discussion for healthcare providers and medical professionals to guide the affected females in planning for pregnancy, safer pharmacotherapies, and to overcome the phobia related with their disease effects.


PDF Share
  1. Shah A, William St. Clair E. Rheumatoid athritis. In: Harrisons’ principle of internal medicine. 19th ed. USA: McGraw-Hill Company; 2015. p. 2139–2145.
  2. Adebajo A, Dunkley L, editors. ABC of rheumatology. John Wiley and Sons; 2018.
  3. Sharma SK, Kumar A, editors. Manual of rheumatology. Ved Chaturvedi. 5th ed. 2018.
  4. Tibbetts TA, DeMayo F, Rich S, et al. Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility. Proc Natl Acad Sci 1999;96(21):12021–12026. DOI: 10.1073/pnas.96.21.12021.
  5. Förger F, Marcoli N, Gadola S, et al. Pregnancy induces numerical and functional changes of CD4+ CD25high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis 2008;67(7):984–990. DOI: 10.1136/ard.2007.075283.
  6. Munoz-Suano A, Kallikourdis M, Sarris M, et al. Regulatory T cells protect from autoimmune arthritis during pregnancy. J Autoimmun 2012;38(2–3):J103–J108. DOI: 10.1016/j.jaut.2011.09.007.
  7. Tham M, Schlör G, Surbek D, et al. 1.59 Reduced inflammatory potential of circulating gammadelta T cells in pregnancy induced improvement of rheumatoid arthritis. Ann Rheum Dis 2014;73(Suppl. 1):A25–A26. DOI: 10.1136/annrheumdis-2013-205124.58.
  8. Crocker IP, Baker PN, Fletcher J. Neutrophil function in pregnancy and rheumatoid arthritis. Ann Rheum Dis 2000;59(7):555–564. DOI: 10.1136/ard.59.7.555.
  9. Krause ML, Makol A. Management of rheumatoid arthritis during pregnancy: challenges and solutions. Open Access Rheumatol 2016;8:23–26. DOI: 10.2147/OARRR.S85340.
  10. Katz PP. Childbearing decisions and family size among women with rheumatoid arthritis. Arthritis Care Res 2006;55(2):217–223. DOI: 10.1002/art.21859.
  11. Østensen M, Wallenius M. Fertility and pregnancy in rheumatoid arthritis. Indian J Rheumatol 2016;11(6):122. DOI: 10.4103/0973-3698.194544.
  12. Ropes MW, Bennett GA, Cobb S, et al. Proposed diagnostic criteria for rheumatoid arthritis: report of a study conducted by a committee of the American Rheumatism Association. Ann Rheum Dis 1957;16(1):118. DOI: 10.1136/ard.16.1.118.
  13. Machold KP, Eberl G, Leeb BF, et al. Early arthritis therapy: rationale and current approach. J Rheumatol Suppl 1998;53:13–19.
  14. Clowse ME, Chakravarty E, Costenbader KH, et al. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res 2012;64(5):668–674. DOI: 10.1002/acr.21593.
  15. Kay A, Bach F. Subfertility before and after the development of rheumatoid arthritis in women. Ann Rheum Dis 1965;24(2):169. DOI: 10.1136/ard.24.2.169.
  16. Brouwer J, Hazes JM, Laven JS, et al. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis 2015;74(10):1836–1841. DOI: 10.1136/annrheumdis-2014-205383.
  17. Jawaheer D, Zhu JL, Nohr EA, et al. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum 2011;63(6):1517–1521. DOI: 10.1002/art.30327.
  18. Brouwer J, Laven JS, Hazes JM, et al. Levels of serum anti–Müllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res 2013;65(9):1534–1538. DOI: 10.1002/acr.22013.
  19. Barrett JH, Brennan P, Fiddler M, et al. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum 1999;42(6):1219–1227. DOI: 10.1002/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G.
  20. De Man YA, Bakker-Jonges LE, Dufour-Van Den Goorbergh CM, et al. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis 2010;69(2):420–423. DOI: 10.1136/ard.2008.104331.
  21. Frisell T, Holmqvist M, Källberg H, et al. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti–citrullinated protein antibody status, number and type of affected relatives, sex, and age. Arthritis Rheum 2013;65(11):2773–2782. DOI: 10.1002/art.38097.
  22. Gur C, Diav-Citrin O, Shechtman S, et al. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004;18(1):93–101. DOI: 10.1016/j.reprotox.2003.10.007.
  23. Lopez JM, Loza E, Carmona L. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). In: Database Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. 2009.
  24. Diav-Citrin O, Blyakhman S, Shechtman S, et al. Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study. Reprod Toxicol 2013;39:58–62. DOI: 10.1016/j.reprotox.2013.04.005.
  25. Chambers CD, Johnson DL, Robinson LK, et al. Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum 2010;62(5):1494–1503. DOI: 10.1002/art.27358.
  26. Levi S, Liberman M, Levi AJ, et al. Reversible congenital neutropenia associated with maternal sulphasalazine therapy. Eur J Pediatr 1988;148(2):174–175. DOI: 10.1007/BF00445938.
  27. Mahadevan U, Wolf DC, Dubinsky M, et al. Placental transfer of anti–tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013;11(3):286–292. DOI: 10.1016/j.cgh.2012.11.011.
  28. Chakravarty EF, Murray ER, Kelman A, et al. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011;117(5):1499–1506. DOI: 10.1182/blood-2010-07-295444.
  29. Förger F, Vallbracht I, Helmke K, et al. Pregnancy mediated improvement of rheumatoid arthritis. Swiss Med Wkly 2012;142(2930). DOI: 10.4414/smw.2012.13644.
  30. Bermas B. Rheumatoid arthritis and pregnancy. UpToDate2012. 2014.
  31. Skorpen CG, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016;75(5):795–810. DOI: 10.1136/annrheumdis-2015-208840.
  32. Flint J, Panchal S, Hurrell A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatol 2016;55(9):1693–1697. DOI: 10.1093/rheumatology/kev404.
  33. Langen ES, Chakravarty EF, Liaquat M, et al. High rate of preterm birth in pregnancies complicated by rheumatoid arthritis. Am J Perinatol 2014;31(01):9–14. DOI: 10.1055/s-0033-1333666.
  34. Rom AL, Wu CS, Olsen J, et al. Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study. Arthritis Rheumatol 2014;66(12):3265–3273. DOI: 10.1002/art.38874.
  35. Carter JD, Ladhani A, Ricca LR, et al. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 2009;36(3):635–641. DOI: 10.3899/jrheum.080545.
  36. O'moráin C, Smethurst P, Doré CJ, et al. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984;25(10):1078–1084. DOI: 10.1136/gut.25.10.1078.
  37. Morris LF, Harrod MJ, Menter MA, et al. Methotrexate and reproduction in men: case report and recommendations. J Am Acad Dermatol 1993;29(5):913–916. DOI: 10.1016/0190-9622(93)70270-4.
  38. Rubbert-Roth A, Goupille PM, Moosavi S, et al. First experiences with pregnancies in RA patients (pts) receiving tocilizumab (TCZ) therapy. Arthritis Rheum 2010;62(Suppl. 10):384. DOI: 10.3109/14397595.2016.114705.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.